Liver transplantation for type lb glycogenosis with reversal of cyclic neutropenia

Clinical Nutrition

Volumn 20, Issue 4, 2001, Pages 375-377

  Martinez Olmos, M A ^a   Lopez Sanroman A ^b   Martin Vaquero P ^a   Molina Perez E ^b   Bárcena, Rafael ^b   Vicente, E ^b   Candela, A ^b   Pallardo Sanchez L F ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Enteral nutrition; Glycogen storage diseases type I.; Liver transplantation; Neutropenia; Nutritional management

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; BILIRUBIN; CARBOHYDRATE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUCOSE 6 PHOSPHATE; GLYCOGEN; HEPATITIS A ANTIBODY; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; METHYLPREDNISOLONE; PYRUVIC ACID; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS; TRIACYLGLYCEROL; UNINDEXED DRUG; URIC ACID; VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; GLYCOGEN STORAGE DISEASE TYPE 1; HUMAN; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; HYPOGLYCEMIA; LIVER TRANSPLANTATION; MALE; MEDICAL CARE; METABOLIC DISORDER; METABOLIC REGULATION; NEUTROPENIA; NUTRITIONAL SUPPORT; TREATMENT PLANNING;

EID: 0034870578     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1054/clnu.2001.0432     Document Type: Article

References (25)

1. Glucose-6-phosphatase in the liver in glycogen storage disease
2. Clinical aspects of glycogen storage disease type I: Summary of the discussions
3. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: Results of the European Study on Glycogen Storage Disease Type I
4. How many forms of glycogen storage disease type I?
5. Defective neutrophil and monocyte functions in glycogen storage disease type Ib: A literature review
6. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease
7. Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease
8. Biochemical evidence for the requirement of continuous glucose therapy in young adults with type 1 glycogen storage disease
9. Physical growth and development of children with type I glycogen storage disease: Comparison of the effects of long-term use of dextrose and uncooked cornstarch
10. Hepatocellular adenomas in glycogen storage disease type I and III: A series of 43 patients and review of the literature
11. Proximal renal tubular acidosis in a child with type I glycogen storage disease
12. Renal disease in type I glycogen storage disease
13. Effect of liver transplantation on hepatic glucose metabolism in a patient with type I glycogen storage disease
14. Long-term outcome of liver transplantation in patients with glycogen storage disease type Ia
15. Ortotopic liver transplantation for hepatic associated metabolic disorders
16. Living-related liver transplantation for inborn errors of metabolism
17. Ortotopic liver transplantation for type I glycogenosis unresponsive to medical therapy
18. Growth in adulthood after liver transplantation for glycogen storage disease type I
19. Treatment of chronic enteritis in glycogen storage disease type IB with granulocyte colony-stimulating factor
20. 2+ mobilization
21. Colony-stimulating factors for neutropenia in glycogen storage disease Ib
22. Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib
23. Treatment with lenogastrim (glycosylated recombinant human granulocyte colony-stimulating factor) and ortotopic liver transplantation for glycogen storage disease type Ib
24. The long-term outcome of patients with glycogen storage disease type Ia
25. Enteral access